Stock Spotlight Archives - Page 254 of 379

FridayDec 20, 2019 2:05 pm

QualityStocksNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Attains Sizeable Revenue Gains During Q3

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, recently announced financial results for third quarter that showed a year-over-year (“YoY”) revenue increase of over 2.5 times. An article discussing the company reads, “HTC’s revenues grew from $1.3 million at the September close of the quarter in 2018 to $3.3 million at the quarter’s end this year, according to the report (http://ibn.fm/t3O4a). . . . The revenue gains continue to reflect growth in the company’s agri-infrastructure operation, but HTC anticipates significant new potential in the explosive growth of cannabinoid-related industries and is building hemp-biomass tolling contracts and extraction…

FridayDec 20, 2019 1:18 pm

QualityStocksNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Achieves 935% YoY Revenue Increase in Q3 2019

LiveWire Ergogenics (OTC: LVVV) recently reported considerable net income increases during Q3 2019, including impressive year-over-year (“YoY”) revenue growth. An article discussing the results reads, “These figures, along with its emphasis on both producing and distributing world-class cannabis throughout the state of California, illuminate the company’s unique positioning in the ever-evolving cannabis industry. . . . In its report, the company noted a 935% boom in revenues, reaching $184,200 for Q3 2019 from $17,790 the same period the prior year (http://ibn.fm/PN6qs). For the 2019 quarter — the three months ended September 30 — LVVV showed a net income of $94,749…

FridayDec 20, 2019 1:12 pm

QualityStocksNewsBreaks – ChineseInvestors.com Inc. (CIIX) Subsidiary Capitalizing on Thriving CBD Market

ChineseInvestors.com’s (OTCQB: CIIX) subsidiary CBD Biotech Co. Ltd. CEO Summer Yun was recently featured in a “Wall Street Journal” video titled “Why China Is Betting Big on CBD” (http://ibn.fm/tiyA1). An article discussing the company reads, “WSJ reporter Stephanie Yang cited Brightfield Group research indicating a 700% jump in CBD sales in the United States through 2019 and growth into a CBD market estimated to reach $23.7 billion by 2023 (http://ibn.fm/Ou4oB). In addition, the ‘Hemp Business Journal’ estimates that in 2018 China generated a yield representing some 11% of the CBD global market (http://ibn.fm/IeXj9). The economic potential of CBD in China is…

ThursdayDec 19, 2019 3:36 pm

QualityStocksNewsBreaks – InsuraGuest Inc. Poised to Exploit Booming European, Asian Hotel Markets through Planned Expansion

InsuraGuest, a Service-as-a-software (SaaS) company, plans to profit from the huge opportunity that exists in the European and Asian hotel markets. An article discussing the company reads, “The company is working on expanding the scope of its InsurTech platform and insurance products to cover European Union member states and the United Kingdom, with plans in motion to launch on the Asian market by mid-2020 (http://ibn.fm/3Q4rK). . . . The European and Asian hotel markets are both more significant than the U.S. market, holding a combined 5.4 billion hotel nights stayed in 2018, compared to 1.1 billion stayed nights in the…

ThursdayDec 19, 2019 3:26 pm

QualityStocksNewsBreaks – Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Eyes Bright Future of Consistent Revenue Growth

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF), a producer of high-quality feature films and episodic television with international appeal, is committed to meeting the growing demand for quality content and expects this dedication to result in increased revenue in the coming years. A recent article discussing the company reads, “Wonderfilm prides itself on sustaining high production quality while providing exponential future value for its shareholders. The company expects $20 million in deferred revenue in early 2020 alone and is positioned to realize $100 million in revenue by 2021. On the stock market, it is undervalued by a factor of 23 with…

ThursdayDec 19, 2019 1:57 pm

QualityStocksNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Q3 2019 Financial Report Reveals Stronger Balance Sheet, Larger Portfolio

Spectrum Global Solutions (OTCQB: SGSI), a leading, single-source provider of next-generation communications network, technology, infrastructure and maintenance solutions, recently released its third-quarter financial report, which included a look at its growing portfolio and stronger balance sheet. An article discussing the company reads, “‘We expect to see encouraging growth through the remainder of the fourth quarter and into 2020, chiefly driven by growing investments in 5G networks across the United States by all major carriers,’ Spectrum Global CEO Roger Ponder stated in a company news release announcing the quarterly results (http://ibn.fm/9GUIk). . . . Gross profits during the third quarter rose…

ThursdayDec 19, 2019 1:53 pm

QualityStocksNewsBreaks – OriginClear, Inc. (OCLN) Foresees Increasing Opportunities in 2020

OriginClear (OTCQB: OCLN), a leading provider of water-treatment solutions, is looking forward to an “amazing year” in 2020, according to CEO Riggs Eckelberry in a recent teleconference. An article discussing the company reads, “During the teleconference, Eckelberry updated listeners on OriginClear’s progress worldwide regarding installations and opportunities with partners and licensees. The CEO specifically mentioned OriginClear’s Modular Water Systems(TM), Progressive Water Treatment and proprietary Electro Water Separation(TM) products. Eckelberry also discussed his recent television interview and provided an update on the company’s global initiatives, focusing on OriginClear’s agreement to enter a joint venture to develop a demonstration unit in the…

FridayDec 13, 2019 3:32 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focuses on Pioneering New Technologies

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is a global innovator in drug-delivery platforms focused on its patented DehydraTECH-based, drug-delivery technology and formulation development. A recent article discussing the company reads, “Earlier this year, Lexaria moved into its new head office that includes a Health Canada-licensed research and development laboratory that is being used to conduct world-leading research into drug-delivery methods and improvements. In addition to accelerating research in the company’s DehydraTECH drug-delivery platform, Lexaria is also considering issuing a limited commercial release of DehydraTECH version 2.0, which has been shown to deliver 811% more CBD into animal blood than generic…

FridayDec 13, 2019 2:47 pm

QualityStocksNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Boosts Output Capacity through Kase Farma Inc. Acquisition

HTC Extraction Systems (TSX.V: HTC), a hemp-biomass processing entity, recently increased its capability and institutional knowledge through the acquisition of California-based Kase Farma Inc. An article discussing the company reads, “Kase Farma is active in the cultivation of hemp as well as the formulation and extraction of cannabinoids from hemp; the company is also licensed in the State of California to perform activities in those areas. At present, the company operates out of a 22,000-square-foot manufacturing facility and is currently implementing a scaled-up, high-throughput extraction facility that will utilize identity-preserved-grown (IPGrowTM), hemp-based cannabinoid biomass. IPGrowTM, according to the U.S. Department…

FridayDec 13, 2019 2:41 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Holds Potential to Supply Biosynthetically Derived Cannabinoids

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, is well positioned to disrupt the cannabis industry supply chain by utilizing its ability to provide biosynthetically derived cannabinoids. A recent article discussing the company reads, “Willow ultimately intends to biosynthetically produce a variety of cannabinoids using biosynthesis, but its first target molecule will be CBD. The company has a fully integrated leadership team based out of Canada and the United States to handle all stages of the upstream cannabinoid development cycle. Additionally, by having two labs in Canada, where cannabis is federally…

Site Search

Company Search

Category: Stock Spotlight